michaela.plechata

Topic: resistance and the development of new antibiotics and the 80th anniversary of the isolation of streptomycin (19th October) – the first drug against tuberculosis.  Link to the TV report (Broadcasted 19th October 2023) : https://ct24.ceskatelevize.cz/veda/3622623-prvni-lek-na-tuberkulozu-byl-objeven-pred-osmdesati-lety-chorobu-se-dosud-nepodarilo

The second scientific conference NIVB Meeting 2023 was held from 2 to 5 October 2023 in Kutná Hora. This year’s meeting built on the success of the first edition in 2022 and also brought together experts from the fields of virology and bacteriology, fostering collaboration and developing breakthrough research. More informations: https://nivb.cz/cs/2023/10/10/nivb-meeting-2023/?rl_gallery_no=1&rl_page=5

On Friday 15th September, 12 lab members (mix Krč+ Vestec) went to Čerčany, either by train or by their own transport. Here, after the draw, the partners went with their canoes to Týnec nad Sázavou. The whole day there was a calm mood, between the crews you could get to know people who normally do

The development of new antibiotics, particularly those effective against resistant bacteria, is one of the global health challenges of our time. Workers at the Institute of Microbiology of the CAS, in international collaboration with the University of Tokyo, have now solved the structure of a key condensing (coupling) enzyme used for antibiotic biosynthesis and elucidated

Our PhD student Lada Hanzlíková presented her results as a poster entitled “Hascofovomycin, a new 4-alkyl-L-proline derivate isolated from marine Actinobacteria” in the Bioscience & Molecular Biology section.

May 15th -16th 2023, Helmholtz Centre for Infection Reasearch, Braunschweig, Germany Our Ph.D. student Michaela Plechata presented her results in the form of a poster at the International Helmholtz Drug Discovery Conference in Braunschweig.